Synapse - Ayca Gucalp

Search Within

Ayca Gucalp

Results (113)

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study

Meeting Abstract

Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: A feasibility study

Journal Article

Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
Breast Cancer Research and Treatment (2022)

Fulltext@MSK | Save

Androgen receptor splice variant-7 in breast cancer: Clinical and pathologic correlations

Journal Article

Ferguson, D. C.; Mata, D. A.; Tay, T. KY.; Traina, T. A.; Gucalp, A.; Chandarlapaty, S.; D'Alfonso, T. M.; Brogi, E.; Mullaney, K.; Ladanyi, M.; more...
Modern Pathology (2022)

Fulltext@MSK | Save

A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-Cell production and immunotherapy response in metastatic breast cancer

Meeting Abstract

Page, D.; Collins, K.; Chun, B.; Sun, Z.; Koguchi, Y.; Redmond, W.; Martel, M.; Wu, Y.; Moxon, N.; Mellinger, S.; more...
Journal for ImmunoTherapy of Cancer (2021)

Fulltext@MSK | Save

Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast

Meeting Abstract

Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
International Journal of Radiation Oncology, Biology, Physics (2021)

Fulltext@MSK | Save

A phase 1b/2 study of the BET inhibitor ZEN003694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

Meeting Abstract

Aftimos, P.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E.; Gucalp, A.; Shah, P.; Mina, L.; Sharma, P.; Bauman, L.; more...
Cancer Research (2021)

Fulltext@MSK | Save

A randomized placebo controlled phase II trial evaluating exemestane with or without enzalutamide in patients with hormone receptor-positive breast cancer

Journal Article

Krop, I.; Abramson, V.; Colleoni, M.; Traina, T.; Holmes, F.; Garcia-Estevez, L.; Hart, L.; Awada, A.; Zamagni, C.; Morris, P. G.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer

Meeting Abstract

Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Genomic profiling of primary and metastatic breast cancer in men

Meeting Abstract

Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
Cancer Research (2020)

Fulltext@MSK | Save